"Removing compounded Semaglutide with no public input, and no consideration of what's actually happening on the ground, is indefensible," said Julia Cantu, attorney for NP2Go
Rhonda Patrick: Well, there's a huge role for inflammation, the cause of inflammation and depression
Research suggests that the peptide may influence several pathways involved in tissue maintenance and repair, including angiogenic signaling, nitric oxide regulation, growth factor activity, and cellular migration
Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest